MDxHealth SA Stock Euronext Bruxelles
Equities
MDXH
BE0974461940
Biotechnology & Medical Research
Sales 2023 | 64.39M 68.81M | Sales 2024 * | 73.53M 78.58M | Capitalization | 62.48M 66.78M |
---|---|---|---|---|---|
Net income 2023 | -39M -41.68M | Net income 2024 * | -26M -27.79M | EV / Sales 2023 | 1.51 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 0.85 x |
P/E ratio 2023 |
-2.37
x | P/E ratio 2024 * |
-2.44
x | Employees | 255 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 97.37% |
Latest transcript on MDxHealth SA
1st Jan change | Capi. | |
---|---|---|
+3.13% | 43.43B | |
+47.53% | 41.69B | |
+8.49% | 41.31B | |
-10.82% | 27.14B | |
+8.26% | 25.28B | |
-23.69% | 18.47B | |
+1.58% | 12.33B | |
+32.83% | 12.59B | |
+6.63% | 11.03B |